Raxar, an antibiotic manufactured by Glaxo Wellcome and approved by the FDA in 1997, was used to treat bacterial infections such as bronchitis, community-acquired pneumonia, gonorrhea, urethritis, and cervicitis.

In 1999 Raxar was removed from the market after questions regarding its safety were raised. Raxar was shown to prolong the heart's QT interval. This prolongation may result in a ventricular arrhythmia known as torsades de pointes. Although rare, such a reaction to Raxar can be fatal. Since Raxar's approval, over 2.65 million prescriptions have been written.

See your doctor if you have experienced serious side effects associated with Raxar. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.



See Also

  1. Antibiotics
  2. Arrhythmia: Overview
  3. QT Interval: Overview
  4. Torsades de Pointes: Overview
  5. Raxar: Frequently Asked Questions
  Name Size